JetMeds, founded in Seattle, Washington, is revolutionizing medication dosing through innovative technology. The company's core mission is to enhance the efficacy of drug delivery while minimizing the amount of medication required. JetMeds offers a suite of products including wearable micro-dispensers, medication cartridges, and accompanying software designed to streamline and optimize the dosing process. Initially focusing on the companion animal medication market, JetMeds plans to expand its platform to production animals and human health sectors.
Notable affiliates include a partnership with a leading company in companion animal medications. JetMeds has demonstrated significant improvements in drug efficacy with its technology, positioning itself for first product sales in the coming year. The company’s advancements have the potential to significantly impact both veterinary and human medicine by reducing medication waste and improving compliance, ultimately contributing to better health outcomes across various markets.
